(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
See the famous winged horse Pegasus fly in the autumn night sky - 2NASA's Artemis astronauts enter final preparations for Moon mission
- 3Vote In favor of Your Favored Kind Of Organic product
- 4SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- 5We tasted one of the 10,000 Hershey's Dubai chocolate bars being resold on eBay. Is it worth the hype?
- Police investigate Lahav 433 officer accused of sexually harassing subordinate policewoman
- 2025 Arctic League telethon raises more than $39k
- 'Backward and upward and tilted': Spaceflight causes astronauts' brains to shift inside their skulls
- KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- Mating injuries may lead scientists to identify dinosaurs’ sex
- IndiGo lands IATA chief Willie Walsh as new CEO
- CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing
- 'Unreal' solar eclipse: Artemis 2 crew just saw one of the rarest sights in spaceflight history
- Spain breaks jobs record with 22 million Social Security contributors
